Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-16 4:34 pm Sale |
2024-09-12 | 13D | Chemomab Therapeutics Ltd. CMMB |
OrbiMed Israel BioFund GP Limited Partnership | 1,860,906 9.990% |
-409,185 (-18.03%) |
Filing History |
| 2024-07-17 8:40 pm Purchase |
2024-07-15 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 17,877,653 9.990% |
5,299,832 (+42.14%) |
Filing History |
| 2024-03-19 9:11 pm Purchase |
2024-03-15 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 12,577,821 19.900% |
7,976,013 (+173.32%) |
Filing History |
| 2024-03-11 7:19 pm Unchanged |
2024-03-11 | 13D | Chemomab Therapeutics Ltd. CMMB |
OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 16.000% |
0 (Unchanged) |
Filing History |
| 2024-03-08 4:30 pm Purchase |
2024-03-06 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 4,601,808 9.900% |
48,319 (+1.06%) |
Filing History |
| 2023-11-15 4:35 pm Unchanged |
2023-11-14 | 13D | Chemomab Therapeutics Ltd. CMMB |
OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 18.300% |
0 (Unchanged) |
Filing History |
| 2023-05-08 4:43 pm Purchase |
2023-05-04 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 4,553,489 9.900% |
1,017,000 (+28.76%) |
Filing History |
| 2023-03-17 4:19 pm Purchase |
2023-02-27 | 13D | 89bio, Inc. ETNB |
OrbiMed Israel BioFund GP Limited Partnership | 3,536,489 10.500% |
3,536,489 (New Position) |
Filing History |
| 2023-01-05 4:31 pm Sale |
2023-01-03 | 13D | Chemomab Therapeutics Ltd. CMMB |
OrbiMed Israel BioFund GP Limited Partnership | 2,270,091 19.700% |
-49,869,729 (-95.65%) |
Filing History |
| 2022-07-01 5:20 pm Sale |
2022-07-01 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 12,356,873 4.600% |
-3,027,545 (-19.68%) |
Filing History |
| 2021-06-28 5:24 pm Sale |
2021-06-24 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 15,384,418 6.000% |
-17,118,837 (-52.67%) |
Filing History |
| 2021-04-07 4:46 pm Unchanged |
2021-04-05 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 13.200% |
0 (Unchanged) |
Filing History |
| 2021-03-26 4:06 pm Purchase |
2021-03-16 | 13D | Chemomab Therapeutics Ltd. CMMB |
OrbiMed Israel BioFund GP Limited Partnership | 52,139,820 24.300% |
52,139,820 (New Position) |
Filing History |
| 2021-03-25 5:26 pm Unchanged |
2021-03-22 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 14.600% |
0 (Unchanged) |
Filing History |
| 2021-01-05 4:38 pm Unchanged |
2020-12-22 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 73,650 0.500% |
0 (Unchanged) |
Filing History |
| 2020-12-16 5:13 pm Purchase |
2020-12-15 | 13D | INNOVATE BIOPHARMACEUTICALS IN INNT |
OrbiMed Israel BioFund GP Limited Partnership | 32,503,255 16.000% |
1,943,734 (+6.36%) |
Filing History |
| 2020-12-04 5:12 pm Sale |
2020-12-02 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 73,650 5.100% |
-103,200 (-58.35%) |
Filing History |
| 2020-11-20 4:39 pm Unchanged |
2020-11-16 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 176,850 12.400% |
0 (Unchanged) |
Filing History |
| 2020-10-13 9:20 pm Purchase |
2020-10-05 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 176,850 14.100% |
176,850 (New Position) |
Filing History |
| 2020-08-18 4:35 pm Unchanged |
2020-08-14 | 13D | NOVUS THERAPEUTICS INC NVUS |
OrbiMed Israel BioFund GP Limited Partnership | 3,183,314 16.400% |
0 (Unchanged) |
Filing History |